Hoarseness: Labs, Diagnosis, and Next Steps

At a glance
- Most common cause / acute viral laryngitis, resolving in 7 to 14 days
- Persistence threshold / hoarseness beyond 4 weeks requires ENT referral per AAO-HNS guidelines
- First-line labs / TSH, free T4, CBC with differential
- Gold-standard diagnostic / flexible laryngoscopy with stroboscopy
- Prevalence / roughly 1 in 3 people experience hoarseness at some point in their lifetime
- Reflux connection / up to 55% of patients with unexplained hoarseness have laryngopharyngeal reflux
- Red flags / stridor, hemoptysis, dysphagia, unintentional weight loss, or neck mass
- Smoking risk / current smokers are 3 times more likely to develop chronic hoarseness than nonsmokers
- Thyroid link / hypothyroidism causes vocal fold edema in approximately 30% of untreated patients
Why Hoarseness Happens
Hoarseness is a change in voice quality, pitch, or volume that results from disruption of normal vocal fold vibration. The vocal folds (commonly called vocal cords) sit inside the larynx and must close symmetrically, vibrate at matched frequencies, and maintain adequate mucosal hydration to produce clear sound. Anything that alters fold mass, tension, or closure pattern will change the voice.
Acute vs. Chronic Causes
Acute hoarseness typically follows an upper respiratory infection. Viral laryngitis accounts for the majority of short-lived episodes, and symptoms resolve within 7 to 14 days without specific treatment [1]. Vocal strain from shouting, prolonged speaking, or singing is the second most frequent acute trigger.
Chronic hoarseness (lasting four or more weeks) has a broader differential. A retrospective review of 1,340 patients presenting to otolaryngology clinics found that the top five chronic causes were vocal fold lesions (28.9%), laryngopharyngeal reflux (24.1%), functional dysphonia (14.3%), vocal fold paralysis (9.8%), and laryngeal malignancy (5.2%) [2]. The distribution shifts with age: malignancy becomes more probable in patients over 50 who smoke.
Structural and Neurological Factors
Vocal fold nodules, polyps, and cysts alter fold mass. These benign lesions are common in professional voice users. Vocal fold paralysis, by contrast, is a neurological problem. The recurrent laryngeal nerve, a branch of the vagus nerve, can be damaged during thyroid surgery, cardiothoracic procedures, or by tumors compressing the nerve along its path. A 2019 systematic review in The Laryngoscope reported that iatrogenic injury during thyroidectomy accounted for 30 to 40% of unilateral vocal fold paralysis cases [3].
When Hoarseness Signals Something Serious
Most hoarseness is benign. But certain features suggest pathology that demands urgent evaluation. The American Academy of Otolaryngology (AAO-HNS) 2018 clinical practice guideline on hoarseness identifies specific red flags: hoarseness with stridor or airway compromise, hemoptysis, progressive dysphagia, a palpable neck mass, or a history of recent head/neck surgery or intubation [4].
Red-Flag Symptoms
Any patient with hoarseness plus unintentional weight loss, heavy tobacco use, and age over 50 should be evaluated for laryngeal carcinoma. The five-year survival rate for early glottic carcinoma (stage I) exceeds 90% with radiation therapy alone, but drops below 50% at stage IV [5]. Early referral saves lives and preserves voice.
Stridor accompanying hoarseness indicates a narrowed airway. This is a medical emergency.
The Four-Week Rule
The AAO-HNS guideline recommends laryngoscopy for any patient whose hoarseness persists beyond four weeks, or sooner if red flags are present [4]. Dr. Seth Dailey, a laryngologist at the University of Wisconsin, has noted: "The four-week threshold exists because most benign causes will have resolved by then. Anything lasting longer deserves a look at the vocal folds."
The Diagnostic Workup for Hoarseness
A systematic evaluation begins with a detailed history and physical examination, then proceeds to targeted laboratory testing and visualization of the larynx. The goal is to identify treatable causes efficiently without over-testing.
History and Physical Examination
Key history questions include the duration of hoarseness, voice use patterns, smoking and alcohol history, recent surgery or intubation, heartburn or throat-clearing habits, and any dysphagia or odynophagia. Physical examination should include palpation of the thyroid gland, assessment of cervical lymph nodes, and a cranial nerve examination.
The AAO-HNS guideline explicitly advises against prescribing antibiotics, corticosteroids, or acid-suppression therapy empirically without first performing laryngoscopy in patients with persistent hoarseness [4]. This recommendation carries a "strong" evidence grade.
Laryngoscopy and Stroboscopy
Flexible nasolaryngoscopy is the gold-standard initial diagnostic tool. It allows direct visualization of the vocal folds in approximately 60 seconds, can be performed in the office, and requires only topical anesthesia. Stroboscopy adds a strobe light synchronized to the patient's vocal frequency, revealing mucosal wave abnormalities that standard white-light laryngoscopy can miss [6].
A study published in the Journal of Voice found that stroboscopy changed or refined the clinical diagnosis in 32% of patients compared with white-light examination alone (N=211) [6]. For this reason, most voice centers now use stroboscopy as part of the initial evaluation.
When Imaging Is Needed
CT or MRI of the neck and chest is not routinely needed for hoarseness evaluation. Imaging is indicated when vocal fold paralysis is identified and the cause is unclear, when a mass lesion is found, or when the clinical picture suggests malignancy. CT with contrast is preferred for evaluating the full course of the recurrent laryngeal nerve from the skull base to the aortic arch [7].
Laboratory Tests for Hoarseness
Lab work is not part of every hoarseness evaluation, but it becomes relevant when the history or examination suggests a systemic cause. Three clinical scenarios routinely warrant laboratory testing.
Thyroid Function Panel
Hypothyroidism causes myxedematous infiltration of the vocal folds, leading to a characteristic low-pitched, rough voice. A study in Clinical Endocrinology found vocal fold edema on laryngoscopy in 31% of patients with untreated hypothyroidism (N=89), and voice quality improved significantly within 12 weeks of levothyroxine therapy [8]. TSH and free T4 should be ordered when hoarseness is accompanied by fatigue, weight gain, cold intolerance, or a goiter on examination.
Inflammatory and Infectious Markers
CBC with differential can reveal leukocytosis (suggesting infection) or eosinophilia (suggesting an allergic or eosinophilic process). Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are useful when autoimmune conditions such as rheumatoid arthritis, relapsing polychondritis, or granulomatosis with polyangiitis are suspected. These conditions can cause cricoarytenoid joint fixation, which mimics vocal fold paralysis [9].
Anti-neutrophil cytoplasmic antibody (ANCA) testing is specifically indicated when granulomatosis with polyangiitis is in the differential. Subglottic stenosis with hoarseness is a classic presentation.
Reflux-Related Testing
Laryngopharyngeal reflux (LPR) is one of the most commonly cited causes of chronic hoarseness, yet its diagnosis remains contentious. The Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) are validated clinical tools, but their specificity is limited [10]. Ambulatory 24-hour pH monitoring with dual-probe (pharyngeal and esophageal) placement is the most objective test, though it is not always available in primary care.
A Cochrane review found limited evidence that empiric proton pump inhibitor (PPI) therapy improves hoarseness attributed to LPR (4 RCTs, N=236), concluding that the diagnosis should be confirmed before committing patients to long-term acid suppression [10]. The 2018 AAO-HNS guideline echoes this position: "Clinicians should not prescribe anti-reflux medications for patients with hoarseness without signs or symptoms of reflux disease" [4].
Treatment Pathways Based on Cause
Treatment depends entirely on the underlying diagnosis. There is no single medication for hoarseness. The management plan follows from the workup findings.
Voice Therapy
Speech-language pathology (SLP) referral for voice therapy is the first-line treatment for functional dysphonia, vocal fold nodules, and muscle tension dysphonia. A randomized controlled trial in the Journal of Speech, Language, and Hearing Research (N=133) showed that structured voice therapy produced significant improvement in Voice Handicap Index scores compared with vocal hygiene education alone at 6 weeks (mean VHI reduction: 14.2 points vs. 4.1 points, P<0.001) [11].
Voice therapy typically involves 6 to 8 sessions over 4 to 8 weeks. Exercises target breath support, resonance placement, and reduction of compensatory muscle tension. Success rates for nodule regression with voice therapy alone range from 50 to 70% in adults [11].
Medical Management
Levothyroxine corrects hypothyroid-related hoarseness, typically within 8 to 12 weeks of achieving euthyroid status [8]. PPI therapy (omeprazole 20 mg twice daily or equivalent) is appropriate only when LPR has been confirmed by objective testing or when classic reflux symptoms coexist. The treatment duration for LPR is generally longer than for gastroesophageal reflux disease (GERD), often 3 to 6 months.
Botulinum toxin injection into the thyroarytenoid muscle is the standard treatment for adductor spasmodic dysphonia. A prospective study reported symptom improvement in 89% of patients (N=901) with a mean benefit duration of 15.1 weeks per injection cycle [12].
Surgical Options
Microlaryngoscopy with excision is indicated for vocal fold polyps and cysts that do not respond to voice therapy. Medialization laryngoplasty (thyroplasty) or injection laryngoplasty is performed for unilateral vocal fold paralysis to bring the paralyzed fold toward the midline. Injection materials include hyaluronic acid (temporary, lasting 3 to 6 months) and calcium hydroxylapatite or autologous fat (longer-lasting). Office-based injection laryngoplasty under local anesthesia has become standard for many patients, reducing the need for general anesthesia [13].
For laryngeal carcinoma, treatment depends on staging. Early-stage glottic cancer is treated with radiation therapy or endoscopic laser excision. A meta-analysis of 8,457 patients with T1 glottic carcinoma found equivalent local control rates between transoral laser microsurgery and radiation (87% vs. 86% at 5 years) but better voice outcomes with laser for select lesions [5].
Building Your Evaluation Timeline
A practical framework helps patients and clinicians decide on the pace of workup. Not every case of hoarseness needs the same urgency.
Week 0 to 2: Watchful Waiting
For hoarseness following a clear upper respiratory infection, with no red flags, observation is appropriate. Voice rest, hydration, and avoidance of irritants (smoke, alcohol, caffeine) are recommended. No labs or imaging are needed at this stage.
Week 2 to 4: Primary Care Evaluation
If hoarseness has not resolved, schedule a primary care visit. The clinician should perform a focused history, thyroid and neck examination, and order TSH and free T4 if thyroid disease is suspected. A trial of vocal hygiene measures (adequate hydration, humidification, voice conservation) is reasonable.
Week 4 and Beyond: ENT Referral
Persistent hoarseness at four weeks triggers referral to otolaryngology for laryngoscopy, per AAO-HNS guidelines [4]. If laryngoscopy reveals a structural lesion, the ENT will determine whether voice therapy, medical management, or surgery is the appropriate next step. If vocal fold paralysis is found, CT from skull base to aortic arch is ordered to evaluate the recurrent laryngeal nerve pathway.
Urgent or Immediate Referral
Red-flag symptoms (stridor, hemoptysis, dysphagia with weight loss, palpable neck mass) warrant same-day or next-day ENT evaluation regardless of hoarseness duration.
Special Populations
Certain groups require modified evaluation approaches.
Professional Voice Users
Teachers, singers, call-center employees, and clergy have higher rates of voice disorders. A cross-sectional study of 1,243 teachers found that 58% reported voice problems during their career, compared with 29% of non-teaching controls [14]. Occupational voice demands should be factored into management decisions, and early SLP referral is often warranted.
Post-Surgical Patients
Hoarseness after thyroidectomy, anterior cervical spine surgery, or cardiothoracic procedures should prompt early laryngoscopy (within 2 weeks) to assess vocal fold mobility. The incidence of temporary recurrent laryngeal nerve palsy after thyroidectomy ranges from 5 to 8%, while permanent palsy occurs in 0.5 to 2% of cases [3].
Older Adults
Age-related vocal fold atrophy (presbylaryngis) is a diagnosis of exclusion. It causes a thin, breathy voice and is common after age 65. Treatment includes voice therapy and, in selected cases, injection augmentation. Malignancy must be ruled out first in any older patient with new hoarseness, particularly those with a smoking history.
Frequently asked questions
›What causes hoarseness?
›How is hoarseness diagnosed?
›When should I worry about hoarseness?
›Can acid reflux cause hoarseness?
›What blood tests are done for hoarseness?
›Does hypothyroidism cause hoarseness?
›What is laryngoscopy and does it hurt?
›How long does hoarseness usually last?
›Can hoarseness be a sign of cancer?
›What doctor should I see for hoarseness?
›Is voice therapy effective for hoarseness?
›Can medications cause hoarseness?
References
- Reveiz L, Cardona AF. Antibiotics for acute laryngitis in adults. Cochrane Database Syst Rev. 2015;(5):CD004783. https://pubmed.ncbi.nlm.nih.gov/25960145/
- Cohen SM, Kim J, Roy N, Asche C, Courey M. Prevalence and causes of dysphonia in a large treatment-seeking population. Laryngoscope. 2012;122(2):343-348. https://pubmed.ncbi.nlm.nih.gov/22271658/
- Jeannon JP, Orabi AA, Bruch GA, Abdalsalam HA, Simo R. Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review. Int J Clin Pract. 2009;63(4):624-629. https://pubmed.ncbi.nlm.nih.gov/19335706/
- Stachler RJ, Francis DO, Schwartz SR, et al. Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngol Head Neck Surg. 2018;158(1_suppl):S1-S42. https://pubmed.ncbi.nlm.nih.gov/29494321/
- Warner L, Chudasama J, Kelly CG, et al. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev. 2014;(12):CD002027. https://pubmed.ncbi.nlm.nih.gov/25503538/
- Mehta DD, Hillman RE. Current role of stroboscopy in laryngeal imaging. Curr Opin Otolaryngol Head Neck Surg. 2012;20(6):429-436. https://pubmed.ncbi.nlm.nih.gov/23128687/
- Rosenthal LH, Benninger MS, Deeb RH. Vocal fold immobility: a longitudinal analysis of etiology over 20 years. Laryngoscope. 2007;117(10):1864-1870. https://pubmed.ncbi.nlm.nih.gov/17828061/
- Junuzović-Žunić L, Ibrahimagić A, Altumbabić S. Voice characteristics in patients with thyroid disorders. Eurasian J Med. 2019;51(2):101-105. https://pubmed.ncbi.nlm.nih.gov/31258345/
- Murano E, Hosako-Naito Y, Tayama N, et al. Bamboo node: primary vocal fold lesion as evidence of autoimmune disease. J Voice. 2001;15(3):441-450. https://pubmed.ncbi.nlm.nih.gov/11575640/
- Hopkins C, Yousaf U, Pedersen M. Acid reflux treatment for hoarseness. Cochrane Database Syst Rev. 2006;(1):CD005054. https://pubmed.ncbi.nlm.nih.gov/16437515/
- Ruotsalainen JH, Sellman J, Lehto L, Verbeek JH. Systematic review of the treatment of functional dysphonia and prevention of voice disorders. Otolaryngol Head Neck Surg. 2008;138(5):557-565. https://pubmed.ncbi.nlm.nih.gov/18439458/
- Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope. 2015;125(8):1751-1757. https://pubmed.ncbi.nlm.nih.gov/25891203/
- Mallur PS, Rosen CA. Vocal fold injection: review of indications, techniques, and materials for augmentation. Clin Exp Otorhinolaryngol. 2010;3(4):177-182. https://pubmed.ncbi.nlm.nih.gov/21217958/
- Roy N, Merrill RM, Thibeault S, Parsa RA, Gray SD, Smith EM. Prevalence of voice disorders in teachers and the general population. J Speech Lang Hear Res. 2004;47(2):281-293. https://pubmed.ncbi.nlm.nih.gov/15157130/